Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fendrix vs Engerix in HIV-infected non-responders to hepatitis B vaccination
2010-023946-58Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Erasmus MC. Started Jan 2011; status: active.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2010-023946-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023946-58.